# A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution

> **NCT05501860** · PHASE3 · COMPLETED · sponsor: **American Genomics, LLC** · enrollment: 249 (actual)

## Conditions studied

- Anesthesia, Local

## Interventions

- **DRUG:** AG-920
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05501860
- **Lead sponsor:** American Genomics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-30
- **Primary completion:** 2022-12-07
- **Final completion:** 2022-12-07
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05501860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05501860, "A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05501860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*